GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

What was recalled

In late December of 2020, a significant safety notice was issued regarding several popular over-the-counter pain relief products found in households across the United States. The U.S. Consumer Product Safety Commission (CPSC) announced that GSK Consumer Health had initiated a voluntary recall affecting five specific brands within the Excedrin family. This action was not taken lightly, but rather as a necessary precaution to ensure that all consumers could rely on the integrity of the packaging designed to protect their families from accidental harm.

The scope of this recall is quite broad, encompassing a wide variety of bottle sizes and formulations that many people keep in their medicine cabinets. Specifically, the affected items include 50-count, 80-count, 100-count, 125-count, 200-count, 250-count, and 300-count bottles. These large quantities are often purchased for long-term use or by households with multiple members who might suffer from headaches or migraines regularly. The specific products involved in this recall are Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. Each of these formulations is packaged in plastic bottles equipped with child-resistant closures, which are intended to be difficult for young children to open.

To help you identify if your specific bottle is part of this recall, it is important to know that the issue lies within the physical structure of the container itself rather than the medication inside. The bottles are made of plastic and feature a closure mechanism designed to meet federal safety standards. However, in some instances, these bottles were manufactured with a defect: a small hole could be present at the bottom of the bottle. This defect is critical because it bypasses the child-resistant cap entirely, creating an easy pathway for curious children to access the pills without needing to open the lid.

If you are trying to determine if your product is part of this specific recall event from December 23, 2020, you should look for the discontinued products list maintained by the manufacturer. A full and definitive list of the recalled products can be found at www.excedrin.com/products/discontinued. This resource serves as the primary reference point for consumers who purchased these items in stores or online prior to the recall date. By checking this official list, you can confirm whether the specific SKU or batch of Excedrin products in your home falls under the safety notice.

Understanding exactly what was recalled helps demystify the situation. It is not a problem with the chemical composition of the aspirin or acetaminophen inside, nor is it an issue with the efficacy of the drug. Instead, it is purely a packaging failure. The plastic bottles, which were supposed to act as a secure barrier, had a potential flaw at their base. This means that even if the cap was screwed on tightly and appeared to be locked in place, the contents could still be accessible through the bottom of the bottle. Recognizing the specific brands and count sizes listed above is the first step in ensuring your home medicine cabinet is safe for everyone, especially children.

The hazard, explained

To understand why this recall matters, it is important to look closely at the specific mechanical failure involved. The issue is not with the medication itself, but with the integrity of the plastic bottle’s base. According to the Consumer Product Safety Commission (CPSC), some of the recalled Excedrin bottles have a defect where a hole forms in the bottom of the container. This might seem like an odd place for a failure point, as we typically worry about lids and caps when it comes to child safety. However, this structural flaw creates a direct, unintended pathway for the contents to escape, completely bypassing the safety features designed to keep them secure.

The primary purpose of the packaging in question is to comply with the Poison Prevention Packaging Act (PPPA). This federal law mandates that certain over-the-counter drugs, particularly those containing aspirin and acetaminophen, must be stored in child-resistant containers. These bottles are engineered with complex closures that require a specific combination of strength and dexterity—usually pushing down while twisting—to open. The design assumes that the bottle itself is a sealed, solid vessel. When a hole exists in the bottom, that assumption is broken. A curious child does not need to master the difficult manipulation required by the cap; they can simply pull the bottle from a shelf or drawer and access the pills directly through the opening at the base.

This physical breach transforms a standard household medicine cabinet into a significant danger zone. The products involved contain two potent active ingredients: aspirin and acetaminophen. While these are safe and effective for adults when taken as directed, they are highly toxic to young children even in small doses. Aspirin can cause Reye’s syndrome, a rare but life-threatening condition affecting the liver and brain, while acetaminophen overdose is a leading cause of acute liver failure in pediatric patients. Because the hole allows immediate access, there is no barrier to prevent a child from grabbing handfuls of pills rather than a single dose.

The risk is compounded by the nature of these medications. They are often stored in plain sight or in easily accessible bathrooms and bedrooms, exactly where children explore. The defect essentially neutralizes the protective shell of the packaging. Without the bottom seal intact, the child-resistant cap becomes irrelevant because the contents are no longer contained within a sealed unit. This is why the hazard is considered so severe: it removes the last line of defense against accidental ingestion, turning a routine headache remedy into a potential poisoning event.

Who is most at risk

While this recall affects a wide array of consumers who have purchased Excedrin products, the primary group at immediate and severe risk consists of young children, particularly those under the age of five. The danger here is not just about accidental ingestion; it is specifically about the failure of the safety mechanism designed to keep these substances out of their hands in the first place. Children are naturally curious and lack the cognitive ability to understand that pills are dangerous medicines rather than candy. When a bottle has a hole in the bottom, it bypasses the child-resistant cap entirely, creating an accessible reservoir of medication that can be reached without any effort or sound.

The specific vulnerability of this age group stems from their small body mass and developing physiology. Even a single dose of the substances involved—acetaminophen and aspirin—can be toxic to a toddler. Acetaminophen overdose is a leading cause of acute liver failure in children, while aspirin ingestion carries the risk of Reye’s syndrome, a rare but life-threatening condition that causes swelling in the liver and brain. Because these medications are over-the-counter items found in nearly every household, they are often within the easy reach of crawling or early walking toddlers who can pull open drawers or climb onto counters to access them.

Beyond young children, other vulnerable individuals may include elderly family members or those with cognitive impairments who might be responsible for administering these medications. If a caregiver is preparing a dose for a child and the bottle has a defect they cannot immediately see, there is a risk of accidental exposure during the process of inspection or transfer. Furthermore, because the products contain aspirin, individuals with bleeding disorders or those already taking blood-thinning medications are at heightened risk if exposed, though the immediate threat in this recall scenario is primarily pediatric poisoning.

It is also important to recognize that households with multiple generations or frequent visitors increase the complexity of safety. A bottle left on a kitchen counter might be seen by a grandparent who assumes it is secure due to the cap, not realizing the bottom is compromised. The lack of reported incidents as of the recall date does not mean the risk was absent; it simply means no confirmed poisonings have been publicly linked to this specific defect yet. Given that these products are ubiquitous in American homes, the potential for exposure is widespread until the defective bottles are identified and removed from circulation.

How to tell if you have the recalled item

Identifying whether a bottle of Excedrin in your medicine cabinet is part of this specific recall requires a careful look at both the product type and the physical condition of the container. Because this issue stems from a manufacturing defect rather than a specific batch number or expiration date, you cannot rely solely on lot codes to determine if your item is affected. Instead, you must verify two things: first, that you possess one of the five specific brands involved in the recall; and second, that the physical bottle exhibits the critical defect—a hole in the bottom.

The recall encompasses five distinct Excedrin products available in a wide variety of sizes. You need to check your bottles to see if they fall into any of these categories: Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, or Excedrin Tension Headache Caplets. It is important to note that this recall applies to bottles containing 50, 80, 100, 125, 200, 250, and 300 counts. If your bottle is one of these types and sizes, it is potentially subject to the recall, regardless of where or when you purchased it.

The most definitive way to confirm if your specific bottle is unsafe is a simple physical inspection. GSK Consumer Health has identified that the hazard arises because some plastic bottles with child-resistant closures may have a hole in the bottom. This defect allows contents to potentially escape and, more dangerously, allows children to access the medication. To check your bottle, pick it up and carefully examine the base. Look closely for any punctures, perforations, or openings that should not be there. These holes might be subtle, so use good lighting and perhaps a magnifying glass if necessary. If you see a hole, do not use the product.

If your bottle does not have a hole in the bottom, it is safe to keep and use as directed. However, if you are unsure whether your specific bottle size or brand was part of this recall, or if you need confirmation beyond what you can see with your eyes, the most reliable source of information is the official discontinued products page. Visit www.excedrin.com/products/discontinued for a full list of the recalled products. This resource provides clarity on which items were included in the December 23, 2020 recall action, ensuring you do not mistakenly discard safe products or overlook unsafe ones.

Remember, the key is the combination of the product type and the physical defect. Even if you have one of the listed Excedrin brands, if the bottom is intact, there is no immediate risk from this specific recall event. Conversely, if you find a hole in any of these bottles, act immediately to secure the medication away from children and contact GSK Consumer Relations for next steps. This careful inspection process ensures you can manage your household safety effectively without unnecessary alarm.

What to do — step by step

Your refund, repair, or replacement options

If you have determined that your Excedrin bottle contains a hole in the bottom, the good news is that GSK Consumer Health has established a straightforward and customer-friendly remedy to resolve the issue. It is important to understand right away that these specific bottles cannot be "repaired" in the traditional sense because the defect is structural—meaning the integrity of the plastic base is compromised. Therefore, the primary option available to you is a full refund via return. The company has designed this process to be as hassle-free as possible, recognizing that dealing with a potential safety hazard should not also become a financial or logistical burden for consumers.

The first step in securing your remedy is to contact GSK Consumer Relations directly. You can reach their dedicated support team by calling 800-468-7746. They are available to assist you Monday through Friday from 8 a.m. to 6 p.m. ET. Alternatively, if you prefer to handle this online, you can visit www.excedrin.com and look for the “safety issue” banner located at the top of the homepage. This digital route is often quicker for those who want to initiate the process without waiting on hold. When you contact them via either method, your goal is to report the defect and request a prepaid shipping label.

Once you have contacted GSK, they will provide you with a prepaid shipping label. This is a crucial detail because it means you do not have to pay out of pocket for the return shipment. You should follow their instructions carefully to attach this label to your box or envelope. The defective bottle must be returned to them so that it can be properly disposed of and removed from circulation. This step is vital not just for your own refund, but for preventing anyone else—including other family members or neighbors—from accidentally accessing the compromised packaging.

After GSK receives your returned item, they will process a full refund for the product. The company has confirmed that this refund covers the entire cost of the recalled bottles, ensuring that you are made whole financially. There are no restocking fees or hidden conditions attached to this remedy; it is a standard recall response aimed at removing hazardous products from homes safely. If you have multiple defective bottles, ensure you include all of them in your return package if instructed to do so, or follow the specific guidance provided by the consumer relations representative.

It is worth noting that this refund process applies specifically to the five Excedrin brands identified in this recall: Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. If your bottles do not have a hole in the bottom, you are not required to return them. In that case, you may retain and use them as directed by the label instructions. However, if you are unsure or anxious about keeping any of these products, you may still contact GSK for guidance, though the remedy is strictly tied to the presence of the defect.

By taking these steps, you not only protect your household from the risk of accidental poisoning but also ensure that the defective units are properly handled. The process is designed to be clear: identify the hole, call or click for a label, ship it back, and receive your money. This approach prioritizes your safety and convenience, allowing you to move forward with confidence knowing that the issue has been resolved completely.

What can happen if you ignore it

When a recall notice arrives in your mail or appears on a news feed, it is natural to feel a momentary spike of anxiety, followed by the pragmatic desire to simply put the item back on the shelf and move on with your day. However, ignoring a recall based on a packaging defect is not merely an inconvenience; it is a gamble with significant health consequences that you do not need to take. The specific hazard identified in this GSK Consumer Health recall is not a malfunction of the medication itself, but a critical failure of the safety barrier designed to protect your family. The bottles contain a hole in the bottom, which effectively renders the child-resistant closure useless. If you continue to use these bottles without inspecting them or returning them, you are leaving a dangerous access point wide open.

The primary danger here is acute poisoning in children. Children are naturally curious and lack the cognitive ability to understand that medicine is not candy. The recalled products contain two potent active ingredients: aspirin and acetaminophen. While these are standard over-the-counter treatments for adults, they are highly toxic to small bodies if ingested in quantities intended for grown-ups. Aspirin can cause serious issues such as stomach bleeding, tinnitus (ringing in the ears), and in severe cases, Reye’s syndrome, a rare but life-threatening condition that causes swelling in the liver and brain. Acetaminophen overdose is particularly insidious because it can lead to acute liver failure, which may not show immediate symptoms but can be fatal if not treated quickly. A hole in the bottom of the bottle means a toddler could simply tip the container over or reach into the base to access the pills, bypassing the complex locking mechanism on the lid entirely.

You might wonder why the recall statistics show zero reported incidents so far. It is important to understand that the absence of reported injuries is a testament to luck, not safety. These products were distributed widely, and while no confirmed cases of poisoning have been logged by the CPSC or GSK yet, the potential for tragedy exists in every home where these defective bottles are kept within reach. Poisoning events often happen quickly and unexpectedly; a child does not need to eat an entire bottle to suffer severe harm—just a few pills can be enough to trigger a medical emergency. By ignoring the recall, you are relying on the hope that no child will ever discover the hole in your specific bottle. That is a risk with no upside.

Beyond the immediate risk of poisoning, there is the secondary danger of delayed treatment. If a child does manage to ingest medication from a defective bottle and symptoms appear later, it can be difficult for medical professionals to determine what was taken if you do not have the specific packaging information handy. Furthermore, continuing to use the product means you are delaying your ability to get a safe, functional replacement. The remedy offered is straightforward: a full refund and a prepaid shipping label. By acting now, you ensure that your home is secure against this specific hazard. By waiting, you are not only risking health but also potentially complicating the recovery process should an accident occur. The peace of mind that comes from knowing your medications are securely stored is worth the few minutes it takes to inspect your bottles and contact GSK Consumer Relations.

Staying safe: broader tips

While this specific recall highlights a manufacturing defect in plastic packaging, it serves as a timely reminder that child safety around medications requires proactive, layered habits rather than reliance on any single feature. The Poison Prevention Packaging Act exists for good reason: standard caps are not foolproof against determined toddlers or curious older children who mimic adult behaviors. To truly safeguard your household, you must treat every over-the-counter and prescription medication as a potential hazard until proven otherwise, regardless of the brand or packaging appearance.

First, establish a strict "high and locked" rule for all medicine storage. Even if a bottle claims to be child-resistant, never store medications in nightstands, bathroom cabinets under the sink, or kitchen counters where children can see them. Children are visual learners; if they cannot see it, they are far less likely to investigate it. Instead, choose a high shelf or a locked cabinet that is out of both sight and reach. For added security, consider using a dedicated locking box for all household medications, not just those currently under recall. This creates a consistent safety baseline so you do not have to mentally categorize which bottles are "safe" and which are not.

Secondly, practice the habit of immediate re-capping. It is incredibly common to place a bottle down on a counter while fetching a glass of water or looking for a spoon, only to forget it seconds later. This brief window is often enough for a child to open a compromised cap or access a bottle with a defect. Always close the lid immediately after use, and verify that you hear the distinct click or feel the resistance indicating a proper seal. Furthermore, never refer to medicine as "candy" to encourage a reluctant child to take it. This can lead to fatal confusion later if they find an unattended bottle and assume the contents are a treat.

Finally, stay informed about product safety without waiting for an emergency. Sign up for email alerts from the Consumer Product Safety Commission (CPSC) and your local health department. Regularly visit www.excedrin.com or other manufacturer sites to check for discontinuations or defects, especially when buying older stock. If you have any doubts about a product’s integrity, err on the side of caution and dispose of it properly. Most pharmacies offer drug take-back programs that are free and safe, preventing these items from ending up in landfills where they might be accessed by others. By making safety a routine part of your home management, you protect your family from both specific recalls and general household hazards.